The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Jul. 11, 2016
Applicants:

Abbvie Deutschland Gmbh & Co. KG, Wiesbaden, DE;

Abbvie Inc., North Chicago, IL (US);

Inventors:

Hervé Geneste, Ludwigshafen, DE;

Michael Ochse, Ludwigshafen, DE;

Karla Drescher, Ludwigshafen, DE;

Jürgen Dinges, North Chicago, IL (US);

Clarissa Jakob, North Chicago, IL (US);

Assignees:

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;

AbbVie Inc., North Chicago, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 217/26 (2006.01); A61K 31/47 (2006.01); C07D 401/06 (2006.01); C07D 413/06 (2006.01); C07D 401/14 (2006.01); C07D 237/32 (2006.01); C07D 417/06 (2006.01); C07D 409/08 (2006.01); C07D 471/04 (2006.01); C07D 217/24 (2006.01); C07D 401/12 (2006.01); C07D 417/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 217/26 (2013.01); A61K 31/47 (2013.01); C07D 217/24 (2013.01); C07D 237/32 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 409/08 (2013.01); C07D 409/12 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01);
Abstract

The present invention relates to compounds which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.


Find Patent Forward Citations

Loading…